David Michael Tehrani, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 3 carriers
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · Stanford Health Care
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tehrani’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A160798 · Current
Licensed to practise in California · since 2019 · expires 2027-02-28 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$511,326
Medicare paid this office $511,326 for 2,014 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 490 | $80,814 | $154 |
| Return visit (30+ min) | 296 | $52,185 | $112 |
| New patient visit (45+ min) | 298 | $40,824 | $137 |
| Short return visit (20+ min) | 388 | $40,685 | $79 |
| Critical care, first 30-74 minutes | 70 | $38,325 | $182 |
See all 46 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 490 | $80,814 | $154 |
| Return visit (30+ min) | 296 | $52,185 | $112 |
| New patient visit (45+ min) | 298 | $40,824 | $137 |
| Short return visit (20+ min) | 388 | $40,685 | $79 |
| Critical care, first 30-74 minutes | 70 | $38,325 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 134 | $30,819 | $104 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 107 | $23,079 | $214 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 370 | $22,218 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 46 | $20,564 | $447 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $17,160 | $151 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $15,784 | $427 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $11,206 | $70 |
| Long return visit (40+ min) | 50 | $9,142 | $155 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 761 | $7,909 | $7 |
| New patient visit (30+ min) | 73 | $7,080 | $97 |
| New patient visit (60+ min) | 33 | $6,587 | $200 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 249 | $5,088 | $15 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 46 | $4,696 | $51 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $4,595 | $66 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 23 | $3,724 | $162 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 161 | $3,705 | $21 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 41 | $3,648 | $78 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $3,562 | $254 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 23 | $3,343 | $145 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $2,747 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 190 | $2,648 | $13 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 43 | $2,609 | $59 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,231 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,181 | $115 |
| Ultrasound of heart, follow-up | 80 | $1,988 | $21 |
| Programming of dual lead pacemaker system | 18 | $1,862 | $72 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 23 | $1,858 | $62 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 159 | $1,817 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 130 | $1,574 | $12 |
| External shock to heart to regulate heart beat | 16 | $1,545 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 210 | $1,452 | $7 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 25 | $1,396 | $56 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 43 | $904 | $21 |
| Injection, regadenoson, 0.1 mg | 40 | $877 | None |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 74 | $489 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 38 | $467 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $364 | $24 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $305 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $225 | $19 |
| Injection, aminophyllin, up to 250 mg | 17 | $120 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $79 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 95 | More than 95% of doctors who do this |
Who their Medicare patients are
2,014 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 20% · Women 53% · Also on Medicaid 29% · Health risk score 1.81. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Chronic kidney disease 45% · Coronary heart disease 44% · Diabetes 37% · Heart failure 33% · Atrial fibrillation 32% · Depression 23% · Cancer 20% · COPD 20% · Dementia 16% · Stroke 16%.
The office billed $3,967,558, Medicare allowed $672,258 and paid $511,326; for 6,933 services of 92 kinds; $1,257 of it was for drugs given in the office and $510,069 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,014 | 6,933 | 76 | 1.81 | $3,967,558 | $511,326 |
| 2023 | 342 | 1,294 | 76 | 1.57 | $935,511 | $110,989 |
| 2019 | 77 | 141 | 72 | 3.13 | $48,313 | $10,863 |
| 2018 | 53 | 102 | 70 | 2.83 | $31,179 | $7,576 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Return visit (30+ min) | 82 | $12,962 | $120 |
| New patient visit (45+ min) | 86 | $12,960 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $11,602 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 107 | $6,596 | $61 |
| Short return visit (20+ min) | 64 | $6,069 | $83 |
| Long return visit (40+ min) | 31 | $6,042 | $163 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $5,842 | $195 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,779 | $445 |
| Critical care, first 30-74 minutes | 15 | $4,629 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 70 | $4,381 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,349 | $70 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $4,139 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,997 | $154 |
| New patient visit (30+ min) | 19 | $1,827 | $96 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,413 | $79 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 33 | $782 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 52 | $722 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $533 | $12 |
| Ultrasound of heart, follow-up | 20 | $516 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 62 | $460 | $7 |
| Telehealth originating site facility fee | 17 | $404 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 29 | $245 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $190 | $11 |
| Ultrasonic guidance for blood vessel access | 14 | $180 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $125 | $6 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,949 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,696 | $150 |
| Short return visit (20+ min) | 44 | $1,811 | $40 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,438 | $90 |
2018: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $4,407 | $88 |
| Short return visit (20+ min) | 36 | $1,561 | $43 |
Medicaid work
$9,175 in 2024
Medicaid paid $9,175 for 717 billed services this clinician did in 2024, up to 84 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 143 | $6,342 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 562 | $2,411 |
| Short return visit (20+ min) | 12 | $422 |
| 2024 | 717 | 3 | 84 | $9,175 |
| 2023 | 91 | 2 | 26 | $3,444 |
| 2019 | 36 | 1 | 13 | $771 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 66 | $2,888 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $556 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 36 | $771 |
Drugs they prescribed that Part D paid
$752,212
Pharmacies billed $752,212 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,926) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
3,258 generic and 668 brand-name prescriptions · $752,212 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 201 | $236,593 | $1,177 |
| Jardiance | 176 | $187,740 | $1,067 |
| Entresto | 67 | $79,938 | $1,193 |
| Xarelto | 55 | $67,070 | $1,219 |
| Farxiga | 36 | $43,946 | $1,221 |
See all 37 drugs
| Eliquis | 201 | $236,593 | $1,177 |
| Jardiance | 176 | $187,740 | $1,067 |
| Entresto | 67 | $79,938 | $1,193 |
| Xarelto | 55 | $67,070 | $1,219 |
| Farxiga | 36 | $43,946 | $1,221 |
| Brilinta | 36 | $33,459 | $929 |
| Repatha | 13 | $14,868 | $1,144 |
| Praluent | 26 | $13,857 | $533 |
| Repatha Sureclick | 15 | $7,613 | $508 |
| Ezetimibe | 122 | $6,855 | $56 |
| Metoprolol | 402 | $6,707 | $17 |
| Rosuvastatin | 296 | $4,921 | $17 |
| Atorvastatin | 341 | $3,083 | $9 |
| Nifedipine Er | 51 | $2,741 | $54 |
| Carvedilol | 294 | $2,506 | $9 |
| Valsartan | 91 | $2,281 | $25 |
| Amlodipine Besylate | 388 | $2,149 | $6 |
| Losartan | 203 | $1,874 | $9 |
| Clopidogrel | 135 | $1,628 | $12 |
| Chlorthalidone | 71 | $1,419 | $20 |
| Amiodarone | 61 | $1,103 | $18 |
| Hydralazine | 57 | $1,094 | $19 |
| Diltiazem 24hr Er (Cd) | 22 | $911 | $41 |
| Furosemide | 146 | $761 | $5 |
| Isosorbide Mononitrate Er | 45 | $595 | $13 |
| Bumetanide | 18 | $568 | $32 |
| Lisinopril | 75 | $510 | $7 |
| Spironolactone | 87 | $475 | $5 |
| Potassium Chloride | 22 | $461 | $21 |
| Nitroglycerin | 37 | $378 | $10 |
| Metoprolol | 42 | $358 | $9 |
| Pravastatin | 33 | $331 | $10 |
| Flecainide Acetate | 14 | $322 | $23 |
| Pantoprazole | 17 | $280 | $16 |
| Digoxin | 11 | $169 | $15 |
| Atenolol | 16 | $56 | $3 |
| Hydrochlorothiazide | 28 | $37 | $1 |
Year by year
| 2024 | 3,926 | 633 | 0% (0) | 17% | $752,212 |
| 2023 | 486 | 183 | 0% (0) | 13% | $76,577 |
| 2022 | 121 | 41 | 0% (0) | None | $6,060 |
| 2021 | 147 | 38 | 0% (0) | 12% | $12,051 |
| 2020 | 46 | 12 | 0% (0) | None | $4,009 |
| 2019 | 43 | 15 | None | None | $1,974 |
| 2018 | 471 | 78 | None | None | $31,430 |
| 2017 | 780 | 119 | None | 16% | $50,527 |
| 2016 | 435 | 78 | None | None | $33,685 |
| 2015 | 104 | 27 | None | 13% | $5,273 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Eliquis | 24 | $27,589 | $1,150 |
| Entresto | 12 | $11,885 | $990 |
| Rosuvastatin | 43 | $1,395 | $32 |
| Clopidogrel | 44 | $1,079 | $25 |
| Metoprolol | 38 | $1,011 | $27 |
| Atorvastatin | 56 | $1,009 | $18 |
| Ezetimibe | 20 | $1,008 | $50 |
| Nifedipine Er | 11 | $806 | $73 |
| Amlodipine Besylate | 45 | $612 | $14 |
| Chlorthalidone | 19 | $478 | $25 |
| Carvedilol | 30 | $361 | $12 |
| Losartan | 18 | $297 | $17 |
| Lisinopril | 18 | $222 | $12 |
2022: 3 drugs
| Rosuvastatin | 21 | $1,146 | $55 |
| Clopidogrel | 26 | $422 | $16 |
| Metoprolol | 16 | $369 | $23 |
2021: 4 drugs
| Atorvastatin | 19 | $413 | $22 |
| Metoprolol | 11 | $193 | $18 |
| Isosorbide Mononitrate Er | 12 | $152 | $13 |
| Clopidogrel | 17 | $141 | $8 |
2018: 15 drugs
| Proair Hfa | 11 | $1,086 | $99 |
| Nifedipine Er | 11 | $950 | $86 |
| Atorvastatin | 48 | $852 | $18 |
| Metoprolol | 16 | $573 | $36 |
| Isosorbide Mononitrate Er | 15 | $311 | $21 |
| Potassium Chloride | 13 | $308 | $24 |
| Amlodipine Besylate | 32 | $217 | $7 |
| Tamsulosin | 13 | $206 | $16 |
| Omeprazole | 13 | $189 | $15 |
| Carvedilol | 18 | $172 | $10 |
| Finasteride | 13 | $137 | $11 |
| Fluticasone Propionate | 11 | $120 | $11 |
| Lisinopril | 18 | $110 | $6 |
| Metformin | 17 | $73 | $4 |
| Hydrochlorothiazide | 18 | $49 | $3 |
2017: 20 drugs
| Lantus Solostar | 13 | $4,975 | $383 |
| Humulin 70-30 | 11 | $4,193 | $381 |
| Lumigan | 12 | $2,014 | $168 |
| Atorvastatin | 92 | $1,597 | $17 |
| Carvedilol | 42 | $1,056 | $25 |
| Proair Hfa | 12 | $891 | $74 |
| Valsartan | 11 | $794 | $72 |
| Metoprolol | 19 | $647 | $34 |
| Amlodipine Besylate | 43 | $472 | $11 |
| Amlodipine Besylate-Benazepril | 16 | $282 | $18 |
| Tamsulosin | 14 | $249 | $18 |
| Omeprazole | 23 | $240 | $10 |
| Lisinopril | 33 | $220 | $7 |
| Finasteride | 12 | $188 | $16 |
| Metformin | 24 | $181 | $8 |
| Pantoprazole | 14 | $178 | $13 |
| Isosorbide Mononitrate Er | 18 | $163 | $9 |
| Fluticasone Propionate | 11 | $96 | $9 |
| Furosemide | 18 | $83 | $5 |
| Hydrochlorothiazide | 17 | $55 | $3 |
2016: 7 drugs
| Atorvastatin | 56 | $1,441 | $26 |
| Amlodipine Besylate | 31 | $344 | $11 |
| Metoprolol | 14 | $340 | $24 |
| Glipizide Er | 17 | $201 | $12 |
| Lisinopril | 14 | $129 | $9 |
| Carvedilol | 12 | $119 | $10 |
| Hydrochlorothiazide | 13 | $92 | $7 |
2015: 1 drug
| Lisinopril | 11 | $36 | $3 |
Money from drug and device companies
$1,053 in 2025
| 2025 | 8 | 36 | None | $1,053 |
| 2024 | 7 | 21 | None | $1,045 |
| 2023 | 5 | 20 | None | $1,732 |
| 2022 | 8 | 48 | None | $12,489 |
| 2021 | 3 | 4 | None | $377 |
| 2020 | 1 | 1 | None | $14 |
| 2019 | 4 | 4 | None | $332 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $342 | 5 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $201 | 8 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $166 | 15 payments
|
| Boston Scientific | Avvigo Guidance System | $148 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $71 | 3 payments
|
| Abbott Laboratories | Aveir | $56 | 1 payment
|
See all 36 published payments
| Medtronic | Meals · 2025-12-11 | Ffrangio | $21 |
| Edwards Lifesciences | Meals · 2025-12-09 | Sapien 3 Ultra Resilia | $22 |
| Edwards Lifesciences | Meals · 2025-11-25 | Sapien 3 Ultra Resilia | $35 |
| Edwards Lifesciences | Meals · 2025-11-11 | Sapien 3 Ultra Resilia | $21 |
| Shockwave Medical | Meals · 2025-11-07 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $36 |
| Abiomed | Meals · 2025-11-06 | None | $33 |
| Shockwave Medical | Meals · 2025-10-15 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $5 |
| Shockwave Medical | Meals · 2025-09-30 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $6 |
| Shockwave Medical | Meals · 2025-09-19 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $5 |
| Boston Scientific | Meals · 2025-09-17 | Avvigo Guidance System | $148 |
| Edwards Lifesciences | Meals · 2025-08-19 | Sapien 3 Ultra Resilia | $34 |
| Abiomed | Meals · 2025-08-12 | None | $119 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-06 | Lifevest | $24 |
| Edwards Lifesciences | Meals · 2025-08-05 | Sapien 3 Ultra Resilia | $22 |
| Shockwave Medical | Meals · 2025-07-29 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3 |
| Shockwave Medical | Meals · 2025-07-25 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $7 |
| Shockwave Medical | Meals · 2025-07-10 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $24 |
| Shockwave Medical | Meals · 2025-07-08 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $15 |
| Edwards Lifesciences | Meals · 2025-06-18 | Sapien 3 Ultra Resilia | $23 |
| Abbott Laboratories | Meals · 2025-06-12 | Aveir | $56 |
| Shockwave Medical | Meals · 2025-05-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $5 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-22 | Lifevest | $25 |
| Edwards Lifesciences | Meals · 2025-05-13 | Sapien 3 Ultra Resilia | $27 |
| Shockwave Medical | Meals · 2025-05-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $18 |
| Shockwave Medical | Meals · 2025-05-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $5 |
| Edwards Lifesciences | Meals · 2025-04-15 | Sapien 3 Ultra Resilia | $18 |
| Shockwave Medical | Meals · 2025-03-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $3 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-13 | Lifevest | $22 |
| Abiomed | Meals · 2025-03-12 | None | $143 |
| Abiomed | Meals · 2025-03-07 | None | $15 |
| Abiomed | Meals · 2025-03-06 | None | $32 |
| Cardiva Medical | Meals · 2025-02-28 | Savvywire | $22 |
| Shockwave Medical | Meals · 2025-02-20 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $12 |
| Shockwave Medical | Meals · 2025-02-05 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $11 |
| Shockwave Medical | Meals · 2025-01-21 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $12 |
| Cardiva Medical | Meals · 2025-01-21 | Optowire | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,045
| Boston Scientific | Watchman Flx | $474 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $337 | 8 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $65 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $60 | 2 payments
|
| Medtronic | Venaseal | $40 | 2 payments
|
| Abiomed | Impella | $36 | 1 payment
|
| Cardiac Dimensions | None | $32 | 1 payment
|
2023: $1,732
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $942 | 8 payments
|
| Abiomed | Impella | $488 | 4 payments
|
| Abbott Laboratories | Perclose Prostyle | $270 | 6 payments
|
| Boston Scientific | Watchman Flx | $18 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $15 | 1 payment
|
2022: $12,489
| Medtronic | Resolute Onyx | $9,357 | 16 payments
|
| Edwards Lifesciences | None | $2,073 | 12 payments
|
| Abbott Laboratories | Hi-Torque Balance | $466 | 13 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $261 | 2 payments
|
| Abiomed | Impella | $183 | 2 payments
|
| Philips Electronics North America | (6575) Coronary Undivided | $92 | 1 payment
|
| Boston Scientific | Rotapro | $38 | 1 payment
|
| Cardiovascular Systems | Diamondback Coronary | $19 | 1 payment
|
2021: $377
| Medtronic | Resolute | $280 | 1 payment
|
| HeartFlow | Ffrct | $50 | 1 payment
|
| Abbott Laboratories | Dragonfly Oct | $47 | 2 payments
|
2020: $14
| Lantheus Medical Imaging | Definity | $14 | 1 payment
|
2019: $332
| Abbott Laboratories | Dragonfly Oct | $172 | 1 payment
|
| Pfizer | Vyndaqel | $125 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Lantheus Medical Imaging | Definity | $18 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Biolife, L.L.C. · Comparing Perclose To Statseal With Perclose in Transcatheter Aortic Valve Replacement Arteriotomy Closure · 2022 | Their institution | $25,000 |
Professional record
- NPI
- 1851771158
- Licence
- CA A160798California A160798: Current · expires 2027-02-28
- Trained
- University of California, Irvine, California College of Medicine, 2015
- Group
- University Healthcare Alliance · Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 5565 W Las Positas Blvd Ste 150, Pleasanton, CA, 94588
- NPI first listed
- 2015-06-02
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.